Literature DB >> 10847427

Textilinins from Pseudonaja textilis textilis. Characterization of two plasmin inhibitors that reduce bleeding in an animal model.

P P Masci1, A N Whitaker, L G Sparrow, J de Jersey, D J Winzor, D J Watters, M F Lavin, P J Gaffney.   

Abstract

The incidence of vein-graft occlusion associated with myocardial infarction and thrombosis following the use of the plasmin inhibitor, aprotinin, to reduce blood loss during vascular surgery has prompted the isolation of an alternative kinetically distinct inhibitor of plasmin from the venom of Pseudonaja textilis. This inhibitor has been called textilinin (Txln) and two distinct forms have been isolated from the Brown-snake venom (molecular weight, 6688 and 6692). A comparison of plasmin inhibitor constants for aprotinin and the Txlns 1 and 2 indicated that the former bound very tightly (inhibitor constant, Ki approximately 10(-11) mol/l), while both of the latter bound less tightly (Ki approximately 10(-9) mol/l). Homogeneity of Txlns 1 and 2 was confirmed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and mass spectrometry. A sequence difference of six amino acids was observed between the two forms of Txln. Txln 1 and 2 showed, respectively, 45 and 43% homology with aprotinin, while there was 58 and 55% homology, respectively, with a plasmin inhibitor from the venom of eastern Taipan, Oxyuranus scutellatus. Both Txlns have six cysteines, like other inhibitors of this group, and homology was determined by alignment of these cysteines. Both have been shown to reduce blood loss by about 60% in a murine tail vein bleeding model. It is proposed that the kinetic profiles of Txln 1 and 2 for plasmin allow the arrest of haemorrhage without the possible threat of thrombosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10847427     DOI: 10.1097/00001721-200006000-00011

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  21 in total

1.  Crystallization and preliminary X-ray analysis of a Kunitz-type inhibitor, textilinin-1 from Pseudonaja textilis textilis.

Authors:  Emma Karin I Millers; Paul P Masci; Martin F Lavin; John de Jersey; Luke W Guddat
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-06-10

Review 2.  Anticoagulant proteins from snake venoms: structure, function and mechanism.

Authors:  R Manjunatha Kini
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

3.  Comparison of active venom components between Eastern brown snakes collected from South Australia and Queensland.

Authors:  Simone Flight; Peter Mirtschin; Paul P Masci
Journal:  Ecotoxicology       Date:  2005-12-23       Impact factor: 2.823

Review 4.  Privileged frameworks from snake venom.

Authors:  T A Reeks; B G Fry; P F Alewood
Journal:  Cell Mol Life Sci       Date:  2015-02-19       Impact factor: 9.261

5.  S2'-subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor -2 domain1-wild-type, Leu17Arg-mutant and aprotinin.

Authors:  K Vadivel; Y Kumar; G I Ogueli; S M Ponnuraj; P Wongkongkathep; J A Loo; M S Bajaj; S P Bajaj
Journal:  J Thromb Haemost       Date:  2016-11-19       Impact factor: 5.824

6.  Hemostatic and toxinological diversities in venom of Micrurus tener tener, Micrurus fulvius fulvius and Micrurus isozonus coral snakes.

Authors:  Ana M Salazar; Jeilyn Vivas; Elda E Sánchez; Alexis Rodríguez-Acosta; Carlos Ibarra; Amparo Gil; Zoila Carvajal; María E Girón; Amalid Estrella; Luis F Navarrete; Belsy Guerrero
Journal:  Toxicon       Date:  2011-05-08       Impact factor: 3.033

7.  Purification and characterization of tenerplasminin-1, a serine peptidase inhibitor with antiplasmin activity from the coral snake (Micrurus tener tener) venom.

Authors:  Jeilyn Vivas; Carlos Ibarra; Ana M Salazar; Ana G C Neves-Ferreira; Elda E Sánchez; Jonás Perales; Alexis Rodríguez-Acosta; Belsy Guerrero
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-09-28       Impact factor: 3.228

8.  Hemostatic properties of a venomic protein in rat organ trauma.

Authors:  Roscoe L Warner; Shannon D McClintock; Adam G Barron; Felix A de la Iglesia
Journal:  Exp Mol Pathol       Date:  2009-09-10       Impact factor: 3.362

Review 9.  Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Med Res Rev       Date:  2014-03-21       Impact factor: 12.944

10.  A spider-derived Kunitz-type serine protease inhibitor that acts as a plasmin inhibitor and an elastase inhibitor.

Authors:  Hu Wan; Kwang Sik Lee; Bo Yeon Kim; Feng Ming Zou; Hyung Joo Yoon; Yeon Ho Je; Jianhong Li; Byung Rae Jin
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.